149
Views
4
CrossRef citations to date
0
Altmetric
Articles

In vitro Anti-colorectal Cancer Potential of the Medicinal Mushroom Ganoderma neo-japonicum Imazeki in Hyperglycemic Condition: Impact on Oxidative Stress, Cell Cycle and Apoptosis

, , ORCID Icon & ORCID Icon
Pages 978-995 | Received 23 Oct 2020, Accepted 10 Apr 2021, Published online: 04 Jun 2021

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Meng Fei Lau, Chia Wei Phan, Vikineswary Sabaratnam & Umah Rani Kuppusamy. (2024) Bibliometric, taxonomic, and medicinal perspectives of Ganoderma neo-japonicum Imazeki: A mini review. Mycology 0:0, pages 1-14.
Read now

Articles from other publishers (3)

Ruohan Zhao, Jinhai Luo & Baojun Xu. (2024) Insights into secondary metabolites and health promoting effects of edible flower Hemerocallis citrina Baroni. Journal of Functional Foods 116, pages 106133.
Crossref
Min You, Lixia Zhao & Li Song. (2023) A novel protein extracted from Hemerocallis citrina Borani inhibits hepatocellular carcinoma cell proliferation by regulating mitochondria-dependent apoptosis and aerobic glycolysis. Food Science and Biotechnology 33:2, pages 465-474.
Crossref
Rui-rui Zhang, Jing Zhang, Xu Guo, Ying-ying Chen, Jin-yue Sun, Jia-lin Miao, M. Carpena, M.A. Prieto, Ning-yang Li, Qing-xin Zhou & Chao Liu. (2023) Molecular mechanisms of the chemical constituents from anti-inflammatory and antioxidant active fractions of Ganoderma neo-japonicum Imazeki. Current Research in Food Science 6, pages 100441.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.